STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
Dr. Erin Knock discusses the applications of pluripotent stem cell-derived lines to investigate Alzheimer's Disease
In this Journal Club, Dr. Erin Knock discusses the applications of pluripotent stem cell-derived lines to investigate Alzheimer’s Disease. The featured paper is Ortiz-Virumbrales et al.’s CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons.
Publish Date:
May 25, 2020
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
STEMCELL Journal Club: Mechanisms of Glioblastoma Resistance
Publish Date: May 25, 2020 -
STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020 -
Modeling Genetic Epilepsies with Induced Pluripotent Stem Cells
Publish Date: June 01, 2017
Explore Our Products
-
BrainPhys™ Neuronal Medium N2-A & SM1 Kit
Kit for serum-free culture of ES/iPS cell-derived neurons in BrainPhys™ Neuronal Medium -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells -
STEMdiff™ SMADi Neural Induction Kit
Serum-free medium kit for highly efficient SMAD inhibition-mediated neural induction of human ES and iPS cells -
Serum-free neurophysiological basal medium for improved neuronal function
